Evidence map›Paper›PMID 41933468›Full record

ArticleBiopolymers2026

Recombinant Fibrinogen-Gamma-Chain as a Crosslinker of Thiol-ene Hydrogels.

Domenic Schlauch, Charlotte Selin Güler, Marina Harzi, Selin Kara, Antonina Lavrentieva, Iliyana Pepelanova

Abstract read
In one paragraph

Article in Biopolymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Domenic SchlauchLeibniz University Hannover, Hanover, Germany.ORCID https://orcid.org/0009-0004-6283-6222
Charlotte Selin GülerLeibniz University Hannover, Hanover, Germany.
Marina HarziLeibniz University Hannover, Hanover, Germany.
Selin KaraLeibniz University Hannover, Hanover, Germany.ORCID https://orcid.org/0000-0001-6754-2814
Antonina LavrentievaLeibniz University Hannover, Hanover, Germany.ORCID https://orcid.org/0000-0003-0003-5572
Iliyana PepelanovaLeibniz University Hannover, Hanover, Germany.ORCID https://orcid.org/0000-0002-2130-3743

Funding

Niedersächsisches Ministerium für Wissenschaft und Kultur
6 · The paper itself

Abstract

Hydrogels based on thiol-ene step-growth chemistry have gained increased attention due to their superior properties over the currently standard materials based on chain growth polymerization. In the thiol-ene reaction, a crosslinker with at least two thiol groups is necessary for network formation. Many currently used crosslinkers exhibit cytotoxic potential, are non-biodegradable, or involve toxic chemicals and relatively complicated procedures in their synthesis, thus hindering their broader application. As an alternative, the use of a protein (fibrinogen gamma chain, FGG) recombinantly expressed in Escherichia coli was investigated. The FGG is part of the multimeric fibrinogen involved in hemostasis. This protein complex is stabilized by disulfide crosslinking. This presence of cysteines in the sequence makes FGG a promising candidate as a thiol donor in thiol-ene reactions. It was shown for the first time, that a cysteine-containing protein expressed in E. coli was capable of forming hydrogels with norbornene functionalized gelatin. An increase in FGG concentration led to higher gel stiffness and a decrease in the swelling ratio. Furthermore, the material exhibited cell adhesive properties and biocompatibility. Overall, a proof-of-principle could be achieved, opening up the use of recombinant proteins without further modifications as crosslinkers in thiol-ene based hydrogels, providing a cost-effective, safe, and scalable material source.

Indexed as

Cross-Linking ReagentsFibrinogenHydrogelsSulfhydryl CompoundsCell AdhesionEscherichia coliGelatinNorbornanesRecombinant ProteinsCross-Linking ReagentsFibrinogenGelatinHydrogelsNorbornanesRecombinant ProteinsSulfhydryl Compoundsfibrinogen‐gamma chaingelatin norborneneGelNBrecombinant hydrogelthiol‐ene reaction

Identifiers

PMID41933468
PMCPMC13049249

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.